Coldstream Capital Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
Coldstream Capital Management's CLB Position: Q2 2025 in Review
Coldstream Capital Management sold out of Core Laboratories (CLB) in Q2 2025, closing a stake of 30 shares — an estimated $450 sold.
Coldstream Capital Management first reported a position in CLB in Q2 2013 and held it in 16 quarters. The position peaked at $483K in Q2 2013. 191 funds tracked by Wall St. Rank hold CLB as of Q2 2025.
- Coldstream Capital Management reported no remaining Core Laboratories position as of Q2 2025 after selling out during the quarter.
- Coldstream Capital Management sold 30 Core Laboratories shares in Q2 2025, an estimated $450.
- Coldstream Capital Management first reported a position in Core Laboratories in Q2 2013 and held it in 16 quarters.
- Coldstream Capital Management's Core Laboratories position peaked at $483K in Q2 2013.
- 191 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2025.
Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.